Skip to main content
spacbrain

Power Analytics Global

Definitive (DA signed)

Information Technology · AI, advanced analytics and quantum-resistant security soluti

What it is
A private company in information technology preparing to list via a SPAC merger. Full profile in progress.
What it’s doing now
Merging with Drugs Made In America Acquisition Corp. (DMAA) — definitive (da signed), announced Jul 20, 2026.
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.
Profile in progress — we only publish what we can verify in filings, and for this company that work isn’t finished. Identity and deal facts above are current; business detail, financials and peers will appear as the filings are parsed.

What the company says about itself

Web research — not audited

Power Analytics is a global technology IoT, data, visualization, and analytics platform company specializing in next-generation energy design, asset optimization, and predictive analytics. Its Paladin platform protects mission critical operations in infrastructure and enterprise markets. EasyPower has acquired DesignBase, Paladin Live and related products from PowerAnalytics.

Markets:
Infrastructure | Operations | Finance | Weather | Marketing | Consumers behavior
Products:
Paladin platform
What our web check found

[WEB-INTEL 2026-08-25] 5 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The transaction aims to merge PAGC with DMAA, resulting in PAGC becoming a publicly traded company, with an expected valuation of about $1 billion." [https://contracts.justia.com/companies/drugs-made-in-america-acquisition-corp-102981/contract/1367137/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "DMAA signs a non-binding LOI with Power Analytics for a de-SPAC deal, targeting about $1.0B valuation, subject to due diligence and a ..." [https://www.stocktitan.net/sec-filings/DMAA/8-k-drugs-made-in-america-acquisition-corp-reports-material-event-56f3114c6756.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "(D.M.A.A.), a SPAC, which has signed a Letter of Intent to merge with Power Analytics Global Corp. Discover the potential $1 billion valuation" [https://www.youtube.com/watch?v=m8p_gTXFqtU] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "DMAA agreed to merge with Power Analytics Global, targeting a $1.0B valuation and a $300M floor; closing needs Form S-4 effectiveness, ..." [https://www.stocktitan.net/sec-filings/DMAA/425-drugs-made-in-america-acquisition-corp-business-combination-commu-0cf5b644eb36.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Billion May 5, 2026, The deal targets a $1.0 billion enterprise value for PAGC, with a $300 million floor valuation. Effective: Apr 29 2026" [https://www.tradingview.com/news/tradingview:e2b78c838864c:0-drugs-made-in-america-acquisition-to-merge-with-power-analytics-global-in-deal-valued-up-to-1-billion/] [WEB-INTEL 2026-08-25] 2 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The deal targets a $1.0 billion enterprise value for PAGC, with a $300 million floor valuation." [https://www.stocktitan.net/sec-filings/DMAA/425-drugs-made-in-america-acquisition-corp-business-combination-commu-0cf5b644eb36.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Effective: Apr 29 2026" [https://www.tradingview.com/news/tradingview:e2b78c838864c:0-drugs-made-in-america-acquisition-to-merge-with-power-analytics-global-in-deal-valued-up-to-1-billion/] [WEB-INTEL 2026-08-25] 4 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The transaction aims to merge PAGC with DMAA, resulting in PAGC becoming a publicly traded company, with an expected valuation of about $1 billion." [https://contracts.justia.com/companies/drugs-made-in-america-acquisition-corp-102981/contract/1367137/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "DMAA signs a non-binding LOI with Power Analytics for a de-SPAC deal, targeting about $1.0B valuation, subject to due diligence and a ..." [https://www.stocktitan.net/sec-filings/DMAA/8-k-drugs-made-in-america-acquisition-corp-reports-material-event-56f3114c6756.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "DMAA agreed to merge with Power Analytics Global, targeting a $1.0B valuation and a $300M floor; closing needs Form S-4 effectiveness, ..." [https://www.stocktitan.net/sec-filings/DMAA/425-drugs-made-in-america-acquisition-corp-business-combination-commu-0cf5b644eb36.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The deal targets a $1.0 billion enterprise value for PAGC, with a $300 million floor valuation. Effective: Apr 29 2026" [https://www.tradingview.com/news/tradingview:e2b78c838864c:0-drugs-made-in-america-acquisition-to-merge-with-power-analytics-global-in-deal-valued-up-to-1-billion/]

Source: https://www.poweranalytics.com/ · captured Aug 25, 2026 · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Power Analytics Global is merging with Drugs Made In America Acquisition Corp. (DMAA) currently marked Deal announced and trading at $10.80 against $10.71 in trust per share.

Headline equity value—

Structure per SEC accession(s) 0001213900-26-079678. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Power Analytics Global going public?

Power Analytics Global has a signed merger with the SPAC Drugs Made In America Acquisition Corp. (DMAA), announced Jul 20, 2026. Deal status: Definitive (DA signed).

Does Power Analytics Global have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other information technology deals
Same sponsor’s other SPACs
  • DMII — Drugs Made In America Acquisition II Corp. · Searching